Patent · US Active

Trypanosoma antigens, vaccine compositions, and related methods

US8778348B2 · kind B2 · utility

4Cited by
78References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 28, 2008
Grant dateJul 15, 2014
Priority date
Expiry dateDec 15, 2029

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/40
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the intersection of the fields of immunology and protein engineering, and particularly to antigens and vaccines useful in prevention of infection by Trypanosoma protozoa. Provided are recombinant protein antigens, compositions, and methods for the production and use of such antigens and vaccine compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.